Guest guest Posted September 4, 2002 Report Share Posted September 4, 2002 Amarillo Biosciences, Inc. Licenses Rights to Low Dose Oral Interferon For Hepatitis B in 40 African Countries; and Executes Dietary Supplement Agreement For Korea http://biz./prnews/020715/dam033_1.html Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.